Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

The following is a satirical article from The Jerusalem Post's annual parodic Purim page, The Jerusalem Roast. Enjoy!

While the outcomes to weight loss drugs can be positive, Consumer Reports (CR) warns there are important considerations—especially for older adults—before starting these treatments.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. [ Sign up for ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Oz's first confirmation hearing as nominee for CMS head is Friday. Back in 2016, Oz was named in a class action lawsuit ...

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...